Sodium Aminosalicylate

What is Sodium Aminosalicylate?

Sodium Aminosalicylate is an important anti-tuberculosis drug, primarily used in the treatment of tuberculosis. It is the sodium salt of para-aminosalicylic acid, often referred to simply as para-aminosalicylic acid (PAS). While not a first-line medication for drug-susceptible tuberculosis, it plays a critical role in combating drug-resistant TB. Administered orally, Sodium Aminosalicylate is a bacteriostatic agent that specifically targets Mycobacterium tuberculosis, the bacterium responsible for the disease, inhibiting its growth and replication.

How Does it Work?

The mechanism of action of Sodium Aminosalicylate involves interfering with the folate synthesis pathway within Mycobacterium tuberculosis. It acts as a competitive inhibitor of dihydropteroate synthase, an enzyme crucial for the synthesis of dihydrofolic acid. Dihydrofolic acid is a vital precursor for tetrahydrofolic acid, which is essential for bacterial DNA and RNA synthesis. By disrupting this pathway, Sodium Aminosalicylate prevents the bacteria from replicating, thus exerting its bacteriostatic effect. This action is distinct from many other antibiotics and is particularly effective when combined with other anti-tuberculosis medications to prevent resistance.

Medical Uses

The primary medical use of Sodium Aminosalicylate is in the treatment of tuberculosis, particularly in challenging cases involving drug resistance.

• Drug-Resistant Tuberculosis (DR-TB)

  Sodium Aminosalicylate is a second-line anti-tuberculosis drug. It is vital for regimens treating multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB), where first-line drugs are ineffective. It offers a crucial therapeutic option to control the infection.

• Combination Therapy

  It is almost always used as part of a multi-drug regimen. This strategy is essential to prevent the emergence of further bacterial resistance and to enhance overall treatment success against Mycobacterium tuberculosis.

Dosage

Dosage of Sodium Aminosalicylate is determined by a healthcare professional based on patient weight, renal function, and the specific tuberculosis regimen. Strict adherence is vital for efficacy and to prevent resistance.

• Adult Dosage

  Typical oral dosage for adults is 8 to 12 grams per day, divided into 2 or 3 doses. It is recommended to take the medication with food to reduce gastrointestinal upset.

• Pediatric Dosage

  For children, dosage is usually around 150 mg/kg/day, also in divided doses.

• Treatment Duration

  Treatment can last 18 to 24 months, or longer for drug-resistant cases. The full course must be completed, even if symptoms improve.

Side Effects

Sodium Aminosalicylate can cause side effects, ranging from mild to serious. Patients should report any adverse reactions to their doctor.

• Common Side Effects

  Most frequently, gastrointestinal issues such as nausea, vomiting, diarrhea, abdominal pain, and loss of appetite occur. Taking the medication with food can often help.

• Serious Side Effects

  • Hypersensitivity Reactions: Rash, fever, joint pain, lymphadenopathy.
  • Hepatic Toxicity: Liver enzyme elevation, hepatitis, jaundice.
  • Renal Impairment: Rare kidney irritation or damage.
  • Thyroid Dysfunction: Can lead to hypothyroidism.
  • Hematologic Abnormalities: Anemia, leukopenia.

  Close medical supervision and regular laboratory monitoring of liver, kidney, and thyroid function, as well as blood counts, are crucial during treatment.

Drug Interactions

Sodium Aminosalicylate can interact with other medications, potentially altering their effects or increasing adverse risks. Inform your doctor about all current medications.

• Isoniazid: Can increase isoniazid levels, raising toxicity risk (e.g., peripheral neuropathy).
• Rifampicin: May interfere with rifampicin absorption; staggered dosing might be needed.
• Oral Anticoagulants (e.g., Warfarin): May potentiate anticoagulant effects, increasing bleeding risk.
• Antacids: Certain antacids can reduce Sodium Aminosalicylate absorption.
• Digoxin: Can decrease digoxin absorption.
• Thyroid Hormones: May interfere with thyroid function; dosage adjustments may be necessary.
• Alcohol: Avoid due to increased risk of hepatic toxicity.

FAQ

• Q: Is Sodium Aminosalicylate a first-line drug for tuberculosis?
  A: No, Sodium Aminosalicylate is a second-line anti-tuberculosis drug, primarily for drug-resistant TB.
• Q: How long does treatment typically last?
  A: Treatment for tuberculosis often lasts 18 to 24 months, or longer for resistant cases.
• Q: Should I take it with food?
  A: Yes, taking Sodium Aminosalicylate with food is recommended to reduce gastrointestinal side effects.
• Q: What if I miss a dose?
  A: Take it when remembered, unless it's near the next dose. Do not double doses.
• Q: Are there dietary restrictions?
  A: Avoid alcohol due to potential liver strain.

Products containing Sodium Aminosalicylate are available through trusted online pharmacies. You can browse Sodium Aminosalicylate-based medications at ShipperVIP or Medicenter.

Summary

Sodium Aminosalicylate is a vital second-line anti-tuberculosis drug, indispensable in the fight against drug-resistant TB. Its bacteriostatic action against Mycobacterium tuberculosis, achieved by inhibiting folate synthesis, makes it a critical component of combination therapies. Successful treatment requires strict adherence to long-term regimens and close medical monitoring for potential side effects and drug interactions. Patients must maintain open communication with healthcare providers to ensure optimal therapeutic outcomes.